Bristol Ifex Website Promotes Off-Label Indications, FDA Ad Division Says
Executive Summary
Bristol-Myers Squibb's Ifex website promotes ifosfamide for unapproved uses through the use of a searchable database of Ifex study summaries, an FDA ad division letter maintains.
You may also be interested in...
Bristol BuSpar Share Halved By Generics; DuPont Deal Shows "Flexibility"
Bristol-Myers Squibb's BuSpar (buspirone) market share has been cut by more than half since the launch of generic products at the end of March.
Bristol BuSpar Share Halved By Generics; DuPont Deal Shows "Flexibility"
Bristol-Myers Squibb's BuSpar (buspirone) market share has been cut by more than half since the launch of generic products at the end of March.
FDA Quality Of Life, Pharmacoeconomic Guidance Development On Hold
FDA development of guidances for including quality of life claims in drug labeling and promotions and for formulary-directed pharmacoeconomic information is on hold until more information is collected.